BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19342834)

  • 21. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
    Wang CX; Ding X; Shuaib A
    Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis and neuroprotection in cerebral ischemia.
    Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
    Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it time to definitely abandon neuroprotection in acute ischemic stroke?
    Sacchetti ML
    Stroke; 2008 Jun; 39(6):1659-60. PubMed ID: 18369169
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.
    Vivien D; Gauberti M; Montagne A; Defer G; Touzé E
    J Cereb Blood Flow Metab; 2011 Nov; 31(11):2119-34. PubMed ID: 21878948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversing stroke in the 2010s: lessons from Desmoteplase In Acute ischemic Stroke-2 (DIAS-2).
    Liebeskind DS
    Stroke; 2009 Sep; 40(9):3156-8. PubMed ID: 19608990
    [No Abstract]   [Full Text] [Related]  

  • 27. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia.
    del Zoppo GJ
    Neuroscience; 2009 Feb; 158(3):972-82. PubMed ID: 18824084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral microvessel responses to focal ischemia.
    del Zoppo GJ; Mabuchi T
    J Cereb Blood Flow Metab; 2003 Aug; 23(8):879-94. PubMed ID: 12902832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
    Shabanzadeh AP; Shuaib A; Wang CX
    Brain Res; 2005 Apr; 1042(1):1-5. PubMed ID: 15823246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch.
    Chavez JC; Hurko O; Barone FC; Feuerstein GZ
    Stroke; 2009 Oct; 40(10):e558-63. PubMed ID: 19745180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
    Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke.
    Arai K; Jin G; Navaratna D; Lo EH
    FEBS J; 2009 Sep; 276(17):4644-52. PubMed ID: 19664070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular aspects of neuroprotection.
    Takahashi M; Macdonald RL
    Neurol Res; 2004 Dec; 26(8):862-9. PubMed ID: 15727270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke.
    Qin W; Li Z; Luo S; Wu R; Pei Z; Huang R
    Neurosci Lett; 2014 May; 569():80-4. PubMed ID: 24704182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New treatments for acute stroke.
    Schehr RS
    Nat Biotechnol; 1996 Nov; 14(11):1549-54. PubMed ID: 9634819
    [No Abstract]   [Full Text] [Related]  

  • 37. Plasminogen activators in ischemic stroke: introduction.
    del Zoppo GJ
    Stroke; 2010 Oct; 41(10 Suppl):S39-41. PubMed ID: 20876502
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke.
    Steiner T; Hacke W
    Eur Neurol; 1998 Jul; 40(1):1-8. PubMed ID: 9693224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical exercise training and neurovascular unit in ischemic stroke.
    Wang X; Zhang M; Feng R; Li WB; Ren SQ; Zhang J; Zhang F
    Neuroscience; 2014 Jun; 271():99-107. PubMed ID: 24780769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular protection in brain ischemia.
    Rodríguez-Yáñez M; Castellanos M; Blanco M; Mosquera E; Castillo J
    Cerebrovasc Dis; 2006; 21 Suppl 2():21-9. PubMed ID: 16651811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.